Retraction
MiR-935 Promotes Clear Cell Renal Cell Carcinoma Migration and Invasion by Targeting IREB2
Paper Information
Record ID:
24168
Author(s):
Publication Date:
December 30, 2019
Retraction Date:
August 17, 2020
(5.2 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (13)
13
Total Citations10
Post-Retraction(76.9%)
3
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
6
Within 1 year
1
After 2+ years
939
Days since retraction (latest)
MiR-24-1-5p Hinders Malignant Phenotypes of Clear Cell Renal Cell Carcinoma by Targeting SHOX2
Jueyi Zhou, Peng Li, Jihong Feng et al. (5 authors)
Biochemical Genetics
Published: Mar 2023
5 citations
5 citations
939 days after retraction
The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Doxorubicin and Topotecan Resistant Ovarian Cancer Cell Lines
Piotr Stasiak, Dominika Kaźmierczak, Karol Jopek et al. (6 authors)
International Journal of Molecular Sciences
Open Access
Published: May 2022
12 citations
12 citations
644 days after retraction
Noncoding way of the metastasis
Bakiye Göker Bağca, Alican Kuşoğlu, Selin Çeşmeli et al. (4 authors)
Elsevier eBooks
Published: Jan 2022
502 days after retraction
MicroRNA-155-5p Targets NR3C2 to Promote Malignant Progression of Clear Cell Renal Cell Carcinoma
Chengquan Yan, Pengfei Wang, Chaofei Zhao et al. (8 authors)
Kidney & Blood Pressure Research
Open Access
Published: Jan 2022
7 citations
7 citations
502 days after retraction
MiR-532-3p suppresses cell viability, migration and invasion of clear cell renal cell carcinoma through targeting TROAP
Bin Gao, Lijuan Wang, Yubo Zhang et al. (8 authors)
Cell Cycle
Open Access
Published: Jul 2021
16 citations
16 citations
338 days after retraction
MicroRNA-935 Directly Targets FZD6 to Inhibit the Proliferation of Human Glioblastoma and Correlate to Glioma Malignancy and Prognosis
Dainan Zhang, Shunchang Ma, Chuanbao Zhang et al. (11 authors)
Frontiers in Oncology
Open Access
Published: Mar 2021
20 citations
20 citations
207 days after retraction
MicroRNA Signature in Renal Cell Carcinoma
Soudeh Ghafouri‐Fard, Zeinab Shirvani-Farsani, Wojciech Branicki et al. (4 authors)
Frontiers in Oncology
Open Access
Published: Nov 2020
42 citations
42 citations
105 days after retraction
Regulation of ferroptosis by non‑coding RNAs in the development and treatment of cancer (Review)
Yajun Luo, Qingmei Huang, Bin He et al. (6 authors)
Oncology Reports
Open Access
Published: Nov 2020
42 citations
42 citations
80 days after retraction
<i>Retracted:</i> miR‐30d‐5p suppresses proliferation and autophagy by targeting ATG5 in renal cell carcinoma
Liang Liang, Zheng Yang, Qian Deng et al. (7 authors)
FEBS Open Bio
Open Access
Published: Nov 2020
24 citations
24 citations
79 days after retraction
Discovery and validation of hsa_circ_0001953 as a potential biomarker for proliferative diabetic retinopathy in human blood
Zheming Wu, Bing Liu, Yan Ma et al. (6 authors)
Acta Ophthalmologica
Open Access
Published: Sep 2020
26 citations
26 citations
24 days after retraction
A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR‐567/ PRDX3 axis in renal cell carcinoma
Rui Yu, Jie Yao, Yu Ren
Journal of Cellular and Molecular Medicine
Open Access
Published: Jul 2020
36 citations
36 citations
18 days before retraction
Exosomes derived from chronic lymphocytic leukaemia cells transfer miR-146a to induce the transition of mesenchymal stromal cells into cancer-associated fibroblasts
Yanli Yang, Jun Li, Yinghua Geng
The Journal of Biochemistry
Published: Jul 2020
33 citations
33 citations
41 days before retraction
Abnormal Expression of miRNAs in RCC
Bixuan Wang
Unknown Journal
Open Access
Published: Jan 2020
229 days before retraction
Quick Stats
Total Citations:
13
Years Since Retraction:
5.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025